CULLINAN THERAPEUTICS, INC. Stock Issued During Period, Shares, Conversion of Units
CULLINAN THERAPEUTICS, INC. (CGEM) reported Stock Issued During Period, Shares, Conversion of Units of 320.23 thousand shares for the 1-month period ending 2021-01-31, per its 10-K filed 2022-03-17.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits · last filed 2022-03-17
- 2021-01-31: Stock Issued During Period, Shares, Conversion of Units 1 month 320.23K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Units 1 month |
|---|---|
| 2021-01-31 | 320.23K shares 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |